BRIEF published on 09/09/2024 at 11:22, 1 year 2 months ago SYNERGY: Monthly declaration of voting rights as of August 31, 2024 Voting Rights Euronext Actions Human Resources SYNERGY
BRIEF published on 08/09/2024 at 09:05, 1 year 3 months ago SYNERGY: Monthly declaration of voting rights as of July 31, 2024 Euronext Paris Share Capital Voting Rights Actions SYNERGY
BRIEF published on 07/04/2024 at 21:38, 1 year 5 months ago SYNERGY: Summary of the liquidity contract - H1 2024 Euronext Paris Liquidity Contract SYNERGY First Half Of 2024
BRIEF published on 07/04/2024 at 21:32, 1 year 5 months ago SYNERGY: Monthly declaration of voting rights as of June 30, 2024 Euronext Paris Share Capital Right To Vote Human Ressources SYNERGY
BRIEF published on 06/06/2024 at 22:31, 1 year 5 months ago SYNERGY: Declaration of voting rights as of May 31, 2024 Share Capital Voting Rights Actions AMF SYNERGY
BRIEF published on 05/30/2024 at 18:35, 1 year 6 months ago SYNERGIE Prepares its Annual General Meeting of June 20, 2024 General Assembly Preparatory Documents Company SYNERGY
Published on 12/05/2025 at 02:35, 2 hours 51 minutes ago Future Fuels Initates Drill Permitting at Hornby; Marketing Update
Published on 12/05/2025 at 01:00, 4 hours 26 minutes ago BEACN Closes First Tranche of Non-Brokered Private Placement
Published on 12/04/2025 at 23:05, 6 hours 21 minutes ago BlackBerry to Announce Third Quarter Fiscal Year 2026 Results on December 18, 2025
Published on 12/04/2025 at 23:00, 6 hours 26 minutes ago NXT Energy Solutions Completes Data Acquisition for SFD Survey
Published on 12/05/2025 at 03:30, 1 hour 55 minutes ago CGTN: What makes cooperation between China and France a two-way success
Published on 12/04/2025 at 23:50, 5 hours 35 minutes ago EQS-Adhoc: Dexus Finance Pty Limited: Dexus prices A$500 million of subordinated notes
Published on 12/04/2025 at 20:25, 9 hours ago Newmark Appoints Globally Recognized Real Estate Executive Peter Trollope to Lead Occupier Solutions
Published on 12/04/2025 at 20:15, 9 hours 11 minutes ago Galimedix Therapeutics presents compelling Phase 1 study results showing excellent safety and pharmacokinetics with oral small molecule GAL-101 at CTAD 2025
Published on 12/04/2025 at 19:10, 10 hours 15 minutes ago SCHOTT Pharma’s preliminary results for fiscal year 2025; outlook for FY 2026 and update of mid-term guidance
Published on 12/04/2025 at 18:00, 11 hours 26 minutes ago Information concerning the total number of voting rights and shares in the share capital as of November 28, 2025
Published on 12/04/2025 at 17:45, 11 hours 41 minutes ago MONTHLY INFORMATION RELATING TO THE TOTAL NUMBER OF VOTING RIGHTS AND SHARES MAKING UP THE SHARE CAPITAL
Published on 12/04/2025 at 17:44, 11 hours 41 minutes ago Net profit attributable to owners of the parent up by 63% to €122 million, driven by business resilience and the improvement in Elior's contribution
Published on 12/04/2025 at 07:01, 22 hours 25 minutes ago bioMérieux launches leading endocrinology testing offer dedicated to enhancing equine health
Published on 12/03/2025 at 18:00, 1 day 11 hours ago Declaration of voting rights at the end of November 2025
